Vanderbilt’s Gamazon named visiting fellow at Cambridge UniversityFeb. 15, 2018, 9:27 AM
Eric Gamazon, PhD, research instructor in the Division of Genetic Medicine at Vanderbilt University School of Medicine, is spending part of the academic year at Cambridge University in England as one of 40 Clare Hall Visiting Fellows.
The fellowships are awarded annually to research scholars from all over the world in diverse fields of study who have made substantial contributions, “have an excellent record of publication and who enjoy an international reputation for intellectual achievement.”
Fellows become Life Members of Clare Hall, a graduate college devoted to advanced studies within Cambridge University. Gamazon also is a visiting scholar in the university’s Department of Medicine and its Medical Research Council (MRC) Biostatistics and Epidemiology units.
Gamazon joined the faculty last September and is a member of the Vanderbilt Genetics Institute at Vanderbilt University Medical Center. He has published more than 110 peer-reviewed publications in statistical genetics, functional genomics and complex trait genetics since 2010.
He is a member of the international Genotype-Tissue Expression Consortium, which is cataloguing genetic variation and its influence on gene expression in all major tissues in the human body, and the T2D-GENES consortium, which seeks to identify genetic variants for type 2 diabetes (T2D).
Gamazon earned a PhD in statistical genetics in 2016 from the Faculty of Medicine of the University of Amsterdam. He previously was a member of the Section of Genetic Medicine at the University of Chicago.